Cargando…
Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy
Chimeric antigen receptor (CAR) T-cell therapy is potentially an effective targeted immunotherapy for glioblastoma, yet there is presently little known about the efficacy of CAR T-cell treatment when combined with the widely used anti-inflammatory and immunosuppressant glucocorticoid, dexamethasone....
Autores principales: | Brummer, Alexander B., Yang, Xin, Ma, Eric, Gutova, Margarita, Brown, Christine E., Rockne, Russell C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820647/ https://www.ncbi.nlm.nih.gov/pubmed/35081104 http://dx.doi.org/10.1371/journal.pcbi.1009504 |
Ejemplares similares
-
Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables
por: Brummer, Alexander B., et al.
Publicado: (2023) -
Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data
por: Sahoo, Prativa, et al.
Publicado: (2020) -
Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings
por: Li, Runpeng, et al.
Publicado: (2023) -
Mathematical modeling of therapeutic neural stem cell migration in mouse brain with and without brain tumors
por: Gomez, Justin, et al.
Publicado: (2022) -
Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma
por: Woodall, Ryan T, et al.
Publicado: (2021)